Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Instituto do Cancer do Estado de São Paulo
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Endeavor Biomedicines, Inc.
Emory University
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Nationwide Children's Hospital
M.D. Anderson Cancer Center
Medical College of Wisconsin
National Cancer Institute (NCI)
Pfizer
Children's National Research Institute
National Cancer Institute (NCI)
Fundació Sant Joan de Déu
University of Virginia
Memorial Sloan Kettering Cancer Center
Children's Oncology Group
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
Samsung Medical Center
Children's Oncology Group
Masonic Cancer Center, University of Minnesota
University of Michigan Rogel Cancer Center
Children's Oncology Group
Fred Hutchinson Cancer Center
NYU Langone Health
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University Hospital Muenster
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)